Brief: Veru Enters Clinical Supply Agreement With Novo Nordisk For Phase 2B Plateau Study - SEC Filing

BRIEF-Veru Enters Clinical Supply Agreement With Novo Nordisk For Phase 2B Plateau Study - SEC Filing

- Veru Inc VERU.O:

  • VERU - ENTERS CLINICAL SUPPLY AGREEMENT WITH NOVO NORDISK FOR PHASE 2B PLATEAU STUDY - SEC FILING

  • VERU - NOVO NORDISK TO SUPPLY WEGOVY AT NO CHARGE FOR VERU PHASE 2B STUDY - SEC FILING

  • VERU - TO PROVIDE NOVO NORDISK WITH INSIGHTS AND UPDATES ON OBESITY TRIAL DESIGN - SEC FILING

  • VERU - GRANTS NOVO NORDISK RIGHT OF FIRST NEGOTIATION FOR ENOBOSARM IN COMBINATION WITH ANY NOVO'S GLP-1 PRODUCTS

Source text: [ID:n0001437749-26-019478]

Further company coverage: VERU.O


((Reuters.Briefs@thomsonreuters.com;))

Recent news on Veru

See all news